Effects of anatomy and particle size on nasal sprays and nebulizers.

Journal Article (Journal Article)

OBJECTIVE: To study the effects of nasal deformity on aerosol penetration past the nasal valve (NV) for varying particle sizes using sprays or nebulizers. STUDY DESIGN: Computed mathematical nasal airway model. SETTING: Department computer lab. SUBJECTS AND METHODS: Particle deposition was analyzed using a computational fluid dynamics model of the human nose with leftward septal deviation and compensatory right inferior turbinate hypertrophy. Sprays were simulated for 10 µm, 20 µm, 50 µm, or particle sizes following a Rosin Rammler particle size distribution (10-110 µm), at speeds of 1, 3, or 10 meters per second. Nebulization was simulated for 1, 3.2, 6.42, or 10 µm particles. Steady state inspiratory airflow was simulated at 15.7 liters per minute. RESULTS: Sprays predicted higher NV penetration on the right side for particle sizes >10 µm, with comparable penetration on both sides at 10 µm. Nearly 100% deposited in the nasal passages for all spray characteristics. Nebulizer predictions showed nearly 100% of particles <6.42 µm and more than 50% of 6.42 µm bypassing both sides of the nose without depositing. Of the nebulized particles that deposited, penetration was higher on the right at 10 µm, with comparable penetration on both sides at 6.42 µm. Spray penetration was highest at 10 µm, with more than 96% penetrating on both sides at 1 and 3 meters per second. Nebulization penetration was also highest at 10 µm (40% on the left, >90% on the right). CONCLUSION: In the presence of a septal deviation, sprays or nebulizers containing 10-µm particles may have good penetration beyond the NV. Nebulized particles <10 µm are likely to be respirable. Additionally, spray speeds above 3 meters per second may limit penetration.

Full Text

Duke Authors

Cited Authors

  • Frank, DO; Kimbell, JS; Pawar, S; Rhee, JS

Published Date

  • February 2012

Published In

Volume / Issue

  • 146 / 2

Start / End Page

  • 313 - 319

PubMed ID

  • 22049020

Pubmed Central ID

  • PMC3636209

Electronic International Standard Serial Number (EISSN)

  • 1097-6817

Digital Object Identifier (DOI)

  • 10.1177/0194599811427519


  • eng

Conference Location

  • England